+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
Antibody Drugs: Technologies and Global Markets - Product Thumbnail Image

Antibody Drugs: Technologies and Global Markets

  • Report
  • September 2024
  • 156 Pages
  • Global
From
From
From
Rheumatoid Arthritis Drugs Market Report 2025 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Monoclonal Antibody Discovery and Analysis Market Report 2022-2032 - Product Thumbnail Image

Monoclonal Antibody Discovery and Analysis Market Report 2022-2032

  • Report
  • December 2022
  • 437 Pages
  • Global
From
Osteoporosis Treatment Market Report 2025 - Product Thumbnail Image

Osteoporosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Alzheimer's Disease Therapeutics Market 2024-2028 - Product Thumbnail Image

Alzheimer's Disease Therapeutics Market 2024-2028

  • Report
  • November 2023
  • 168 Pages
  • Global
From
Systemic Lupus Erythematosus - Pipeline Insight, 2025 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
From
From
Loading Indicator